Mark D. Reeth, General Counsel&VP Corporate Compliance at SALIX PHARMACEUTICALS LTD (SLXP), sold 11,537 shares at $40.32 ($463K) on 2011-07-05, disclosed to the SEC on 2011-07-06.
Scheduled sale ($463k) by General Counsel&VP Corporate Compliance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.83 | 4,180 | $166K | 35.9% |
| 2 | $40.32 | 7,357 | $297K | 64.1% |
| Total | $40.14 avg | 11,537 | $463K | 100% |
| Filing → |
| SLXP | SELL | 2010-06-15 | $155K | — | Filing → |
| SLXP | SELL | 2010-05-19 | $126K | — | Filing → |
| SLXP | SELL | 2009-11-24 | $80K | — | Filing → |